📰 Human Use News
Page 32 - Human Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.
November 19, 2023
The rapid advances of artificial intelligence (AI) and its application for various tasks and at the business level are rapidly transforming society
November 16, 2023
VYVGART® is now approved for both intravenous (IV) and self-administered subcutaneous (SC) use in Europe argenx is committed to continued collaboration...
November 14, 2023
The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended the approval of subcutaneous atezolizumab for all indications in which the intravenous formulation is approved, including certain types of lung, liver, bladder, and breast cancer
November 14, 2023
The European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion supporting the approval of momelotinib for the treatment of disease-related splenomegaly or symptoms in adult patients with moderate to severe anemia with primary myelofibrosis, post–polycythemia vera myelofibrosis, or post–essential thrombocytopenia myelofibrosis who have not been exposed to a JAK inhibitor or who had received prior ruxolitinib.
November 14, 2023
After a re-examination procedure, the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion on the conditional marketing authorization application for adagrasib in the treatment of adult patients with KRAS G12C–mutated advanced non–small cell lung cancer whose disease progressed following at least 1 prior systemic treatment.
November 13, 2023
GSK PLC (LSE:GSK, NYSE:GSK) has received a positive recommendation from the European Medicines Agencys Committee for Medicinal Products for Human Use...
November 13, 2023
GSK PLC (LSE:GSK, NYSE:GSK) has received a positive recommendation from the European Medicines Agencys Committee for Medicinal Products for Human Use...
November 13, 2023
GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia. The opinion from the Committee...
November 13, 2023
YAVNE, Israel, Nov. 13, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. MDWD, a fully integrated biopharmaceutical company focused on next-generation enzymatic…
November 13, 2023
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a positive opinion recommending approval of GSK plc's GSK…